Delivery Order SPE2DB24D2101-SPE2DB25FKPKA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Adderall XR 30 mg capsules (100-count units) with a contract ceiling value of $2,607.02. This is a non-set-aside, competitively awarded firm fixed-price delivery order with an ultimate completion date of September 10, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Adderall XR 30 mg capsules (100-count units) with a contract value of $1,765.86. This firm fixed-price delivery order, with an ultimate completion date of August 29, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger pharmaceutical supply contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,957.52 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100 count) on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $1,142.47 to AmerisourceBergen Drug Corp for Adderall XR 30 mg capsules (quantity: 100s) on September 8, 2025, with completion scheduled for September 9, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in the same city....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Adderall XR 15 mg capsules (100-count units) with a ceiling value of $5.38K. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 4, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency awarded a $5,384.37 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Adderall XR 10 mg capsules (100-count units). This firm fixed-price contract, with an ultimate completion date of August 1, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made on a competitive, non-set-aside basis and will be performed at the vendor's corporate office location...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,309.38 to AmerisourceBergen Drug Corp for the supply of Adderall XR 30 mg capsules (100-count units). This non-set-aside, competitively awarded contract utilizes a firm fixed price structure and was executed on September 9, 2025, with an ultimate completion date of September 10, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a continuation of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Adderall XR 30 mg capsules (quantity: 100 units) with a ceiling value of $1,759.80. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract calls for completion by September 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) valued at $1,721.09. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competitive procurement. The contract's place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,097.62 for Adderall XR 5 mg capsules (100-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPKADelivery Order
The Defense Logistics Agency awarded a $2,562.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Adderall XR 30 mg capsules in quantities of 100. This competitively awarded, non-set-aside contract is scheduled for completion by September 11, 2025, with performance occurring at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle valued through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. As a prime contractor under the DLA's pharmaceutical supply chain, the company delivers a broad portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems. This delivery order for a controlled substance medication reflects the company's established capability to fulfill federal procurement requirements for pharmaceutical products essential to military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/10/25 |